Share Twitter LinkedIn Facebook Email Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., shares Safety Profile of Once-Weekly Regimen Was comparable opposed to the twice-weekly regimen at Annual Meeting 2018
AACR IO 2025: Revolutionary Insights into Desmoplastic Melanoma Treatment – Kari L Kendra, MD, PHD AACR 5 Mins Read
What Are the Latest Melanoma Treatment Advances? [87 Slides] Justin Moyers, MD Melanoma and Skin 3 Mins Read